263 related articles for article (PubMed ID: 15620863)
1. Sustained release of lidocaine from Poloxamer 407 gels.
Ricci EJ; Lunardi LO; Nanclares DM; Marchetti JM
Int J Pharm; 2005 Jan; 288(2):235-44. PubMed ID: 15620863
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
[TBL] [Abstract][Full Text] [Related]
3. Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur.
Zhang L; Parsons DL; Navarre C; Kompella UB
J Control Release; 2002 Dec; 85(1-3):73-81. PubMed ID: 12480313
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R
Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800
[TBL] [Abstract][Full Text] [Related]
5. [Diffusion behaviors of drugs in thermosensitive in situ gels].
Wei G; Lu WY; Zheng JM
Yao Xue Xue Bao; 2004 Mar; 39(3):232-5. PubMed ID: 15171663
[TBL] [Abstract][Full Text] [Related]
6. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation.
Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G
Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763
[TBL] [Abstract][Full Text] [Related]
7. Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels.
Ricci EJ; Bentley MV; Farah M; Bretas RE; Marchetti JM
Eur J Pharm Sci; 2002 Nov; 17(3):161-7. PubMed ID: 12393144
[TBL] [Abstract][Full Text] [Related]
8. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
[TBL] [Abstract][Full Text] [Related]
9. Sustained-release of urease from a poloxamer gel matrix.
Fults KA; Johnston TP
J Parenter Sci Technol; 1990; 44(2):58-65. PubMed ID: 2338605
[TBL] [Abstract][Full Text] [Related]
10. Development of thermo-sensitive injectable hydrogel with sustained release of doxorubicin: rheological characterization and in vivo evaluation in rats.
Xuan JJ; Yan YD; Oh DH; Choi YK; Yong CS; Choi HG
Drug Deliv; 2011 Jul; 18(5):305-11. PubMed ID: 21226548
[TBL] [Abstract][Full Text] [Related]
11. Controlled release and dura mater permeability of lidocaine and ibuprofen from injectable poloxamer-based gels.
Paavola A; Yliruusi J; Rosenberg P
J Control Release; 1998 Mar; 52(1-2):169-78. PubMed ID: 9685947
[TBL] [Abstract][Full Text] [Related]
12. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
[TBL] [Abstract][Full Text] [Related]
13. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.
Sherif S; Bendas ER; Badawy S
Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of thermosensitive poloxamer 407 gel systems for the sustained release of estradiol in a fish model.
Cespi M; Bonacucina G; Pucciarelli S; Cocci P; Perinelli DR; Casettari L; Illum L; Palmieri GF; Palermo FA; Mosconi G
Eur J Pharm Biopharm; 2014 Nov; 88(3):954-61. PubMed ID: 25194925
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of morphine from a poloxamer 407 gel.
Jansen MM; Verzijl JM; Burger DM; Hekster YA
Int J Pharm; 2013 Aug; 452(1-2):266-9. PubMed ID: 23707252
[TBL] [Abstract][Full Text] [Related]
16. Injectable thermally responsive mucoadhesive gel for sustained protein delivery.
Mayol L; Biondi M; Quaglia F; Fusco S; Borzacchiello A; Ambrosio L; La Rotonda MI
Biomacromolecules; 2011 Jan; 12(1):28-33. PubMed ID: 21142090
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of a formulation of butorphanol tartrate in a poloxamer 407 base intended for use as a parenterally administered slow-release analgesic agent.
Laniesse D; Smith DA; Knych HK; Mosley C; Guzman DS; Beaufrère H
Am J Vet Res; 2017 Jun; 78(6):677-687. PubMed ID: 28541144
[TBL] [Abstract][Full Text] [Related]
18. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
19. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow.
Ali M; Horikawa S; Venkatesh S; Saha J; Hong JW; Byrne ME
J Control Release; 2007 Dec; 124(3):154-62. PubMed ID: 17964678
[TBL] [Abstract][Full Text] [Related]
20. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis.
Kelly HM; Deasy PB; Ziaka E; Claffey N
Int J Pharm; 2004 Apr; 274(1-2):167-83. PubMed ID: 15072793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
